Search results
Crinetics Unveils 'Stunning' Results In Highly Anticipated Study
Investor's Business Daily· 6 days agoCrinetics unveiled "stunning" results Monday from a study of a drug that tamps down on levels of a...
Spruce Biosciences (SPRB) Falls 86% in a Month: Here's Why
Zacks via Yahoo Finance· 3 months agoSpruce Biosciences SPRB stock has declined 86.1% in the past month due to the failure of a key study...
Neurocrine Leads 5 Stocks To Watch In Sickly Market
Investor's Business Daily· 2 years agoNeurocrine Biosciences and Vertex Pharmaceuticals are among five medical stocks to put on your radar this week, as the sector shows some resilience amid...
3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success
InvestorPlace via Yahoo Finance· 3 months agoBiotech stocks have always been high-risk and high-reward, with the futures and fortunes of...
S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind
Investor's Business Daily· 3 months agoS&P 500 components Dexcom, Blackstone and Royal Caribbean lead a list of stocks that also include...
Neurocrine Biosciences Inc (NBIX) Reports 29% YoY Growth in Q3 2023 Net Product Sales
GuruFocus.com via Yahoo Finance· 7 months agoINGREZZA (valbenazine) Q3 2023 net product sales reached $486 million, a 29% YoY growth. Neurocrine Biosciences Inc (NASDAQ:NBIX) raised its 2023 net sales guidance for INGREZZA to $1.82 - $1.84 ...
Ways to Induce Periods
Verywell Health via Yahoo News· 1 year agoWhile there are many reported ways to induce your period, very few have been backed up by scientific research. Hormonal medications, also used by those...
Boarding school ignored teen’s sickness complaints before she died, ex-staffers say
NBC News via Yahoo News· 1 year agoTaylor Goodridge, 17, died at Diamond Ranch Academy, a boarding school for troubled teens in Utah....
12 Stocks Billionaire Steve Cohen Just Bought and Sold
Insider Monkey via Yahoo Finance· 6 months agoIn this article, we’re going to take a look at 12 stocks billionaire Steve Cohen just bought and...
